NOD2 and inflammatory bowel disease: This study illustrating inhibition of de novo sphingolipid synthesis with myriocin suppressed Salmonella-induced NOD2-mediated hBD-2 expression (Fig. 4), links the relationship between membrane sphingolipids and inflammatory bowel diseases.